New date for publication of interim report 3

Today, ExpreS2ion Biotech Holding AB (“ExpreS2ion”) announces that the Company will publish its interim report for the period January – September 2019 on November 14th, 2019, instead of the previously scheduled November 21st, 2019. The aim of the advanced publication is to coordinate the release with the Company’s planned participation in a major public investor event during the second half of November 2019.Certified Adviser Svensk Kapitalmarknadsgranskning AB Telephone: +46 70 755 95 51 E-mail: ca@skmg.se